Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher

Influenza and pneumococcal vaccine coverage among adults hospitalized with acute respiratory infection in France: A prospective cohort study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.

Journal of medical economics·2024

[Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].

La Revue de medecine interne·2023

Heterologous prime boost COVID 19 vaccination.

Infectious diseases now·2022

[Fabry disease: A review].

La Revue de medecine interne·2020

Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Eiken syndrome presenting as pseudohypoparathyroidism due to PTH1R gene pathogenic variant.

JCEM case reports·2026

Diagnostic challenges in primary aldosteronism evaluation and finerenone use.

Journal of medical case reports·2026

An Unexpected Cause of Severe Steatohepatitis in a Young Male.

Gastroenterology·2026

High metanephrines with adrenal hemorrhage: a diagnostic dilemma.

JCEM case reports·2026

Timepoint-Specific Percentile Reference Curves for C-Reactive Protein and Erythrocyte Sedimentation Rate After Uncomplicated Primary Reverse Shoulder Arthroplasty: A Single-Center Cohort Study.

Diagnostics (Basel, Switzerland)·2026

Facts Do Not Organise Themselves: Whewell and the Conceptual Crisis in Medicine.

Journal of evaluation in clinical practice·2026

Related Experiment Videos

Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher

Related Concept Videos

Influenza and pneumococcal vaccine coverage among adults hospitalized with acute respiratory infection in France: A prospective cohort study.

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population.

[Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].

Heterologous prime boost COVID 19 vaccination.

[Fabry disease: A review].

Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012-2018: a retrospective observational study.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Eiken syndrome presenting as pseudohypoparathyroidism due to PTH1R gene pathogenic variant.

Diagnostic challenges in primary aldosteronism evaluation and finerenone use.

An Unexpected Cause of Severe Steatohepatitis in a Young Male.

High metanephrines with adrenal hemorrhage: a diagnostic dilemma.

Timepoint-Specific Percentile Reference Curves for C-Reactive Protein and Erythrocyte Sedimentation Rate After Uncomplicated Primary Reverse Shoulder Arthroplasty: A Single-Center Cohort Study.

Facts Do Not Organise Themselves: Whewell and the Conceptual Crisis in Medicine.

Related Experiment Videos

Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher

Related Concept Videos

Related Articles